Home›Search›Exploration of Targeted Anti-tumor Therapy

Exploration of Targeted Anti-tumor Therapy

Open Exploration Publishing Inc · China · Est. 1980

ISSN2692-3114

SJR Q3✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Risk

Score Breakdown

✓ Scopus Q3+12

✓ DOAJ Verified+15

Total37

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Score

0.677

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.418

Total Works

372

Total Citations

3,320

2yr Mean Citedness

4.57

Free JIF alternative

Aims & Scope

Exploration of Targeted Anti-tumor Therapy aims to publish high-quality research articles, reviews, and perspectives on targeted anti-tumor therapies. The journal covers a broad range of topics including molecular mechanisms of cancer, drug discovery and development, precision oncology, biomarkers, and clinical trials. It also welcomes submissions on emerging areas such as cancer immunotherapy, liquid biopsy, and artificial intelligence in cancer care.

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Average · median is 15 wks

SJR Rank

Top 75% in field

General Information

Country / RegionChina

Primary LanguageEnglish

1st Year Published1980

FrequencyMonthly

StatusActive (last: 2026)

Total Publications372

OA Since2019

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~13 weeks

Acceptance Rate33%

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

Portico

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Open Exploration Publishing Inc

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2692-3114

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2013

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ3

OncologyQ3

Subject Classification

Scopus Categories

Cancer ResearchOncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsLung Cancer Treatments and MutationsCancer Cells and MetastasisLung Cancer Research StudiesImmunotherapy and Immune ResponsesHER2/EGFR in Cancer ResearchImmune cells in cancerProtein Degradation and InhibitorsPancreatic and Hepatic Oncology Research